Karla Plevová
Impact in
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunodeficiency and Autoimmune Disorders
Papers in
- Genetics 37
- Chronic Lymphocytic Leukemia Research 35
- Immunology 22
- Immunodeficiency and Autoimmune Disorders 11
- Galectins and Cancer Biology 6
Karla Plevová
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 75
- Genetics 451
- Immunology 519
- Pathology and Forensic Medicine 279
- Cancer Research 189
- Hematology 124
Countries citing papers authored by Karla Plevová
This map shows the geographic impact of Karla Plevová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karla Plevová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karla Plevová more than expected).
Fields of papers citing papers by Karla Plevová
This network shows the impact of papers produced by Karla Plevová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karla Plevová. The network helps show where Karla Plevová may publish in the future.
Co-authors
The 25 scholars most cited alongside Karla Plevová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 0 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 24 | |
| 7 | 2021 | 17 | |
| 8 | 2020 | 20 | |
| 9 | 2019 | 9 | |
| 10 | 2019 | 5 | |
| 11 | 2018 | 10 | |
| 12 | High throughput immunoprofiling of chronic lymphocytic leukemia patients assigned to stereotyped subset #4 : novel insights into the depth, diversity and temporal dynamics of clonal evolution | 2017 | 1 |
| 13 | 2017 | 49 | |
| 14 | 2016 | 116 | |
| 15 | 2015 | 52 | |
| 16 | 2014 | 303 | |
| 17 | 2013 | 82 | |
| 18 | 2013 | 1 | |
| 19 | 2013 | 12 | |
| 20 | 2011 | 29 |
About Karla Plevová
Karla Plevová is a scholar working on Genetics, Immunology, Pathology and Forensic Medicine, Cancer Research and Molecular Biology, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (35 papers), Lymphoma Diagnosis and Treatment (15 papers), Immunodeficiency and Autoimmune Disorders (11 papers), Galectins and Cancer Biology (6 papers), Glycosylation and Glycoproteins Research (5 papers), Single-cell and spatial transcriptomics (4 papers), MicroRNA in disease regulation (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). The work is most often cited by research in Genetics (451 citations), Immunology (519 citations), Pathology and Forensic Medicine (279 citations), Cancer Research (189 citations) and Hematology (124 citations). Karla Plevová has collaborated with scholars based in Czechia, Sweden and Greece. Frequent co-authors include Šárka Pospı́šilová, Šárka Pavlová, Michael Doubek, Yvona Brychtová, Boris Tichý, Dmitriy M. Chudakov, Maria A. Turchaninova, Ilgar Z. Mamedov, Dmitriy A. Bolotin and Ekaterina M. Merzlyak. Their work appears in journals such as Blood, Leukemia, British Journal of Haematology, Leukemia Research and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.